Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 2/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL27474015 | 1.00 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL8542408 | 1.00 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL2545621 | 0.98 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL27838107 | 0.98 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Heptane SCHEMBL4621147 | 0.98 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Heptane SCHEMBL4126646 | 0.96 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL6419639 | 0.96 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL28081841 | 0.96 | ALDH1A1 (0.58) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Ethyl Acetate SCHEMBL7604155 | 0.95 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10FAAHTSHR | |
| Hexane SCHEMBL5790855 | 0.93 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10FAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110794079-A | Identification method of ephedra and aconitine preparation | 刘圣梅 | 2020-02-14 | — | — | CN | claimed |
| CN-101732515-A | Quality test method of Dianxianning tablets | KUNMING ZHENHUA PHARMACEUTICAL | 2010-06-16 | — | — | CN | claimed |
| CN-116482241-A | Liquid chromatography-mass spectrometry combined method and kit for detecting metabolites of vitamin D | 广州凯普医药科技有限公司 | 2023-07-25 | — | — | CN | disclosed |
| WO-2023008577-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | 国立大学法人神戸大学 | 2023-02-02 | — | — | WO | disclosed |
| US-10711033-B2 | Branched chain-containing aromatic compound | AJINOMOTO CO., INC. (JP) | 2020-07-14 | — | — | US | disclosed |
| CN-110794079-A | Identification method of ephedra and aconitine preparation | 刘圣梅 | 2020-02-14 | — | — | CN | disclosed |
| CN-110446699-A | 2(1H) -quinolinone derivatives | TAISHO PHARMACEUTICAL CO LTD | 2019-11-12 | — | — | CN | disclosed |
| US-20190070129-A1 | COMPOSITION COMPRISING PANDURATIN OR FINGERROOT (BOESENBERGIA PANDURATA) EXTRACT FOR TREATING, PREVENTING, OR AMELIORATING BONE LOSS DISEASE | NEWTREE CO., LTD. (KR) | 2019-03-07 | — | — | US | disclosed |
| CN-108697754-A | A kind of composition containing Pan Duoting or finger root (the recessed lip ginger of panduriform) extract for treating, preventing or improving bone resorption disease | 新树有限公司 | 2018-10-23 | — | — | CN | disclosed |
| US-9705097-B2 | Metal complex and light-emitting device containing the metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-11 | — | — | US | disclosed |
| US-20170008922-A1 | BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND | AJINOMOTO CO., INC. (JP) | 2017-01-12 | — | — | US | disclosed |
| US-4564609-A | NERVOUS SYSTEM DISORDERS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1986-01-14 | — | — | US | disclosed |
| EP-0157609-A2 | Lipid derivatives their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-10-09 | — | — | EP | disclosed |
| EP-0123444-A1 | 4-Substituted-2-azetidinone compound, process of producing the compounds, and medicaments containing the compounds | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1984-10-31 | — | — | EP | disclosed |
| EP-0082501-A1 | Beta-lactam compound and a pharmaceutical composition containing the same | KYOWA HAKKO KOGYO CO., LTD (JP) | 1983-06-29 | — | — | EP | disclosed |
| US-4358602-A | IMMUNOLOGY ENHANCER, ANTIINFLAMMATORY AGENT, ENZYME INHIBITOR | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kao (JP) | 1982-11-09 | — | — | US | disclosed |
| US-4345096-A | 3-/P-OXYPHENYLALKYL/GLUTARIC ACID | E. R. SQUIBB & SONS, INC. (US) | 1982-08-17 | — | — | US | disclosed |
| US-4230621-A | TRACERS, HYDROXYPHENYLGLUTARIC ACID DERIVATIVES | E. R. SQUIBB & SONS, INC. (US) | 1980-10-28 | — | — | US | disclosed |
| US-4221725-A | CHEMICAL INTERMEDIATE | E. R. SQUIBB & SONS, INC. (US) | 1980-09-09 | — | — | US | disclosed |
| US-4202824-A | Physiologically active derivatives of esterastin | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1980-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190070129-A1 | COMPOSITION COMPRISING PANDURATIN OR FINGERROOT (BOESENBERGIA PANDURATA) EXTRACT FOR TREATING, PREVENTING, OR AMELIORATING BONE LOSS DISEASE | SOST, KLF10, BACH1 | ALDH1A1 4342/4885LMNA 4431/4885HSD17B10 3593/4885 |
| US-10711033-B2 | Branched chain-containing aromatic compound | VIP, IAPP, BCAT1 | ALDH1A1 3285/4885LMNA 2252/4885HSD17B10 664/4885 |
| US-20170008922-A1 | BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND | VIP, IAPP, BCAT1 | ALDH1A1 3285/4885LMNA 2252/4885HSD17B10 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.